4//SEC Filing
Morrow Phuong Khanh 4
Accession 0000950170-23-053819
CIK 0001674416other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 5:52 PM ET
Size
5.1 KB
Accession
0000950170-23-053819
Insider Transaction Report
Form 4
Morrow Phuong Khanh
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-10-13+16,667→ 16,667 totalExercise: $44.31Exp: 2033-10-13→ Common Shares (16,667 underlying)
Footnotes (1)
- [F1]This option was granted on October 13, 2023 with respect to 16,667 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001928989
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 5:52 PM ET
- Size
- 5.1 KB